Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.88 USD | +3.47% | +4.07% | -10.07% |
May. 31 | Prelude Therapeutics Files for $400 Million Mixed Shelf | MT |
May. 07 | Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 206M |
---|---|---|---|---|---|
Net income 2024 * | -128M | Net income 2025 * | -138M | EV / Sales 2024 * | - |
Net cash position 2024 * | 201M | Net cash position 2025 * | 150M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.26
x | P/E ratio 2025 * |
-2.66
x | Employees | 128 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.93% |
Latest transcript on Prelude Therapeutics Incorporated
1 day | +3.47% | ||
1 week | +4.07% | ||
Current month | -0.26% | ||
1 month | +2.95% | ||
3 months | -6.11% | ||
6 months | +16.36% | ||
Current year | -10.07% |
Managers | Title | Age | Since |
---|---|---|---|
Krishna Vaddi
FOU | Founder | 58 | 16-01-31 |
Bryant Lim
DFI | Director of Finance/CFO | 53 | 23-01-31 |
Jane Huang
PSD | President | 51 | 22-04-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 21-01-24 |
Paul Friedman
CHM | Chairman | 81 | 16-06-30 |
David Bonita
BRD | Director/Board Member | 48 | 16-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 3.84 | +2.40% | 35 244 |
24-06-07 | 3.75 | -0.79% | 17,970 |
24-06-06 | 3.78 | +0.27% | 34,492 |
24-06-05 | 3.77 | +5.90% | 22,647 |
24-06-04 | 3.56 | -3.52% | 59,106 |
Delayed Quote Nasdaq, June 10, 2024 at 12:50 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.07% | 206M | |
+48.93% | 57.87B | |
+41.65% | 40.25B | |
-7.27% | 39.94B | |
-5.96% | 28.54B | |
+12.30% | 26.4B | |
-20.23% | 19.33B | |
+30.22% | 12.4B | |
-0.66% | 12.23B | |
+24.68% | 12.2B |
- Stock Market
- Equities
- PRLD Stock